Jeff Kindler is retiring after four-and-a-half years as CEO of Pfizer, reports The Wall Street Journal. In a statement, Kindler said that his time there was "extremely exciting and rewarding" though also "extremely demanding" on him personally.
...and receive Daily News bulletins.
Already have an account?Login Now.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.